Remarkable mechanisms in microbes to resist phage infections

Annual Review of Virology

Volumn 1, Issue 1, 2014, Pages 307-331

  Dy, Ron L ^a   Richter, Corinna ^a,c   Salmond, George P C ^b   Fineran, Peter C ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c LUND UNIVERSITY   (Sweden)

Author keywords

Abortive infection; Argonaute; Bacteriophages; CRISPR Cas; Horizontal gene transfer; Phage resistance; Toxin antitoxin

Indexed keywords

ARGONAUTE PROTEIN; LIPOPOLYSACCHARIDE; MEMBRANE PROTEIN; TOXIN ANTIBODY;

ADSORPTION; ARTICLE; BACTERIAL GENOME; BACTERIAL MEMBRANE; BACTERIAL VIRULENCE; BACTERIOPHAGE; BIOGENESIS; BORDETELLA; CHROMOSOME REPLICATION; CLUSTERED REGULARLY INTERSPACED SHORT PALINDROMIC REPEAT; CONFORMATIONAL TRANSITION; CRISPR CAS SYSTEM; DNA PROTEIN COMPLEX; ENZYME SPECIFICITY; ESCHERICHIA COLI; EXTRACELLULAR MATRIX; HORIZONTAL GENE TRANSFER; HOST PARASITE INTERACTION; IMMUNE SYSTEM; INFECTION PREVENTION; LACTOCOCCUS LACTIS; LEGIONELLA PNEUMOPHILA; MICROORGANISM; NONHUMAN; NUTRIENT CYCLING; NUTRIENT LIMITATION; PARASITISM; POINT MUTATION; PRIORITY JOURNAL; PROTEIN QUATERNARY STRUCTURE; REVERSE TRANSCRIPTION; RHODOBACTER SPHAEROIDES; SALMONELLA ENTERICA SEROVAR TYPHIMURIUM; STREPTOCOCCUS THERMOPHILUS; STREPTOMYCES COELICOLOR; THERMUS THERMOPHILUS; TYPE III SECRETION SYSTEM; VIBRIO CHOLERAE; VIRUS RESISTANCE; WILD TYPE;

PROKARYOTA;

EID: 84929153360     PISSN: 2327056X     EISSN: 23270578     Source Type: Journal    
DOI: 10.1146/annurev-virology-031413-085500     Document Type: Article

References (180)

1. Summers WC. 2011. In the beginning. Bacteriophage 1:50-51
2. Chanishvili N. 2012. Phage therapy-history from Twort and d'Herelle through Soviet experience to current approaches. Adv. Virus Res. 83:3-40
3. Kutter E, Sulakvelidze A. 2005. Bacteriophages: Biology and Applications. Boca Raton, FL: CRC
4. Petty NK, Evans TJ, Fineran PC, Salmond GP. 2007. Biotechnological exploitation of bacteriophage research. Trends Biotechnol. 25:7-15
5. Faust K, Raes J. 2012. Microbial interactions: from networks to models. Nat. Rev. Microbiol. 10:538-50
6. Van Valen L. 1974. Molecular evolution as predicted by natural selection. J. Mol. Evol. 3:89-101
7. Paterson S, Vogwill T, Buckling A, Benmayor R, Spiers AJ, et al. 2010. Antagonistic coevolution accelerates molecular evolution. Nature 464:275-78
8. Wommack KE, Colwell RR. 2000. Virioplankton: viruses in aquatic ecosystems. Microbiol. Mol. Biol. Rev. 64:69-114
9. Fuhrman JA. 1999. Marine viruses and their biogeochemical and ecological effects. Nature 399:541-48
10. Weinbauer MG. 2004. Ecology of prokaryotic viruses. FEMS Microbiol. Rev. 28:127-81
11. Brüssow H, Canchaya C, Hardt WD. 2004. Phages and the evolution of bacterial pathogens: from genomic rearrangements to lysogenic conversion. Microbiol. Mol. Biol. Rev. 68:560-602
12. Labrie SJ, Samson JE, Moineau S. 2010. Bacteriophage resistance mechanisms. Nat. Rev. Microbiol. 8:317-27
13. Samson JE, Magadan AH, Sabri M, Moineau S. 2013. Revenge of the phages: defeating bacterial defences. Nat. Rev. Microbiol. 11:675-87
14. Kostyuchenko VA, Leiman PG, Chipman PR, Kanamaru S, van Raaij MJ, et al. 2003. Threedimensional structure of bacteriophage T4 baseplate. Nat. Struct. Biol. 10:688-93
15. Riede I, Eschbach ML. 1986. Evidence that TraT interacts with OmpA of Escherichia coli. FEBS Lett. 205:241-45
16. Achtman M, Kennedy N, Skurray R. 1977. Cell-cell interactions in conjugating Escherichia coli: role of traT protein in surface exclusion. Proc. Natl. Acad. Sci. USA 74:5104-8
17. Koebnik R. 1999. Structural and functional roles of the surface-exposed loops of theβ-barrelmembrane protein OmpA from Escherichia coli. J. Bacteriol. 181:3688-94
18. HynesWL, Hancock L, Ferretti JJ. 1995. Analysis of a second bacteriophage hyaluronidase gene from Streptococcus pyogenes: evidence for a third hyaluronidase involved in extracellular enzymatic activity. Infect. Immun. 63:3015-20
19. Hanlon GW, Denyer SP, Olliff CJ, Ibrahim LJ. 2001. Reduction in exopolysaccharide viscosity as an aid to bacteriophage penetration through Pseudomonas aeruginosa biofilms. Appl. Environ. Microbiol. 67:2746-53
20. Forde A, Fitzgerald GF. 2003. Molecular organization of exopolysaccharide (EPS) encoding genes on the lactococcal bacteriophage adsorption blocking plasmid, pCI658. Plasmid 49:130-42
21. Destoumieux-Garzon D, Duquesne S, Peduzzi J, Goulard C, Desmadril M, et al. 2005. The ironsiderophore transporter FhuA is the receptor for the antimicrobial peptide microcin J25: role of the microcin Val11-Pro16 β-hairpin region in the recognition mechanism. Biochem. J. 389:869-76
22. Meyer JR, Dobias DT,Weitz JS,Barrick JE,Quick RT,LenskiRE. 2012. Repeatability and contingency in the evolution of a key innovation in phage λ. Science 335:428-32
23. Raetz CRH. 1990. Biochemistry of endotoxins. Annu. Rev. Biochem. 59:129-70
24. Qimron U, Marintcheva B, Tabor S, Richardson CC. 2006. Genomewide screens for Escherichia coli genes affecting growth of T7 bacteriophage. Proc. Natl. Acad. Sci. USA 103:19039-44
25. Hu B, Margolin W, Molineux IJ, Liu J. 2013. The bacteriophage T7 virion undergoes extensive structural remodeling during infection. Science 339:576-79
26. Sutherland IW. 1995. Polysaccharide lyases. FEMS Microbiol. Rev. 16:323-47
27. Baker JR, Dong S, Pritchard DG. 2002. The hyaluronan lyase of Streptococcus pyogenes bacteriophage H4489A. Biochem. J. 365:317-22
28. BesslerW,Freund-Mölbert E, Knüfermann H, Rudolph C, Thurow H, Stirm S. 1973.Abacteriophageinduced depolymerase active on Klebsiella K11 capsular polysaccharide. Virology 56:134-51
29. Glonti T, Chanishvili N, Taylor PW. 2010. Bacteriophage-derived enzyme that depolymerizes the alginic acid capsule associated with cystic fibrosis isolates of Pseudomonas aeruginosa. J. Appl. Microbiol. 108:695-702
30. Hoskisson PA, SmithMC. 2007. Hypervariation and phase variation in the bacteriophage "resistome." Curr. Opin. Microbiol. 10:396-400
31. Veening JW, SmitsWK, Kuipers OP. 2008. Bistability, epigenetics, and bet-hedging in bacteria. Annu. Rev. Microbiol. 62:193-210
32. Decker KB, James TD, Stibitz S, Hinton DM. 2012. The Bordetella pertussis model of exquisite gene control by the global transcription factor BvgA. Microbiology 158:1665-76
33. Stibitz S, AaronsonW, Monack D, Falkow S. 1989. Phase variation in Bordetella pertussis by frameshift mutation in a gene for a novel two-component system. Nature 338:266-69
34. Liu M, Deora R, Doulatov SR, Gingery M, Eiserling FA, et al. 2002. Reverse transcriptase-mediated tropism switching in Bordetella bacteriophage. Science 295:2091-94
35. Medhekar B, Miller JF. 2007. Diversity-generating retroelements. Curr. Opin. Microbiol. 10:388-95
36. Doulatov S, Hodes A, Dai L, Mandhana N, Liu M, et al. 2004. Tropism switching in Bordetella bacteriophage defines a family of diversity-generating retroelements. Nature 431:476-81
37. Arambula D, Wong W, Medhekar BA, Guo H, Gingery M, et al. 2013. Surface display of a massively variable lipoprotein by a Legionella diversity-generating retroelement. Proc. Natl. Acad. Sci. USA 110:8212-17
38. Seed KD, Faruque SM,Mekalanos JJ, Calderwood SB,Qadri F, Camilli A. 2012. Phase variableOantigen biosynthetic genes control expression of the major protective antigen and bacteriophage receptor in Vibrio cholerae O1. PLoS Pathog. 8:e1002917
39. Kim M, Ryu S. 2012. Spontaneous and transient defence against bacteriophage by phase-variable glucosylation of O-antigen in Salmonella enterica serovar Typhimurium. Mol. Microbiol. 86:411-25
40. Kanamaru S, Leiman PG, Kostyuchenko VA, Chipman PR, Mesyanzhinov VV, et al. 2002. Structure of the cell-puncturing device of bacteriophage T4. Nature 415:553-57
41. Mosig G, Lin GW, Franklin J, Fan WH. 1989. Functional relationships and structural determinants of two bacteriophage T4 lysozymes: a soluble (gene e) and a baseplate-associated (gene 5) protein. New Biol. 1:171-79
42. Moak M, Molineux IJ. 2004. Peptidoglycan hydrolytic activities associated with bacteriophage virions. Mol. Microbiol. 51:1169-83
43. Lu MJ,Henning U. 1994. Superinfection exclusion by T-even-type coliphages. Trends Microbiol. 2:137-39
44. Mahony J, McGrath S, Fitzgerald GF, van Sinderen D. 2008. Identification and characterization of lactococcal-prophage-carried superinfection exclusion genes. Appl. Environ. Microbiol. 74:6206-15
45. Sun X, Gohler A, Heller KJ, Neve H. 2006. The ltp gene of temperate Streptococcus thermophilus phage TP-J34 confers superinfection exclusion to Streptococcus thermophilus and Lactococcus lactis. Virology 350:146-57
46. Bebeacua C, Lorenzo Fajardo JC, Blangy S, Spinelli S, Bollmann S, et al. 2013. X-ray structure of a superinfection exclusion lipoprotein from phage TP-J34 and identification of the tape measure protein as its target. Mol. Microbiol. 89:152-65
47. Tock MR, Dryden DT. 2005. The biology of restriction and anti-restriction. Curr. Opin. Microbiol. 8:466-72
48. O'Sullivan D, Twomey DP, Coffey A, Hill C, Fitzgerald GF, Ross RP. 2000. Novel Type I restriction specificities through domain shuffling of HsdS subunits in Lactococcus lactis. Mol. Microbiol. 36:866-75
49. McGrath S, Seegers JF, Fitzgerald GF, van Sinderen D. 1999. Molecular characterization of a phageencoded resistance system in Lactococcus lactis. Appl. Environ. Microbiol. 65:1891-99
50. Walkinshaw MD, Taylor P, Sturrock SS, Atanasiu C, Berge T, et al. 2002. Structure of Ocr from bacteriophage T7, a protein that mimics B-form DNA. Mol. Cell 9:187-94
51. Bandyopadhyay PK, Studier FW, Hamilton DL, Yuan R. 1985. Inhibition of the Type I restrictionmodification enzymes EcoB and EcoKby the gene 0.3 protein of bacteriophageT7. J. Mol. Biol. 182:567-78
52. Stewart FJ, Panne D, Bickle TA, Raleigh EA. 2000. Methyl-specific DNA binding by McrBC, a modification-dependent restriction enzyme. J. Mol. Biol. 298:611-22
53. Sutherland E, Coe L, Raleigh EA. 1992. McrBC: a multisubunit GTP-dependent restriction endonuclease. J. Mol. Biol. 225:327-48
54. Janosi L, Yonemitsu H, Hong H, Kaji A. 1994. Molecular cloning and expression of a novel hydroxymethylcytosine-specific restriction enzyme (PvuRts1I) modulated by glucosylation of DNA. J. Mol. Biol. 242:45-61
55. Chinenova TA, Mkrtumian NM, Lomovskaia ND. 1982. Genetic characteristics of a new phage resistance trait in Streptomyces coelicolor A3(2). Genetika 18:1945-52 (in Russian)
56. Sumby P, Smith MC. 2003. Phase variation in the phage growth limitation system of Streptomyces coelicolor A3(2). J. Bacteriol. 185:4558-63
57. Sumby P, Smith MC. 2002. Genetics of the phage growth limitation (Pgl) system of Streptomyces coelicolor A3(2). Mol. Microbiol. 44:489-500
58. Laity C, Chater KF, Lewis CG, Buttner MJ. 1993. Genetic analysis of thePdblC31-specific phage growth limitation (Pgl) system of Streptomyces coelicolor A3(2). Mol. Microbiol. 7:329-36
59. Makarova KS,Wolf YI, van der Oost J, Koonin EV. 2009. Prokaryotic homologs of Argonaute proteins are predicted to function as key components of a novel system of defense against mobile genetic elements. Biol. Direct. 4:29
60. Swarts DC, Jore MM, Westra ER, Zhu YF, Janssen JH, et al. 2014. DNA-guided DNA interference by a prokaryotic Argonaute. Nature 507:258-61
61. Sheng G, Zhao H, Wang J, Rao Y,Tian W, et al. 2014. Structure-based cleavagemechanism of Thermus thermophilus Argonaute DNA guide strand-mediated DNA target cleavage. Proc. Natl. Acad. Sci. USA 111:652-57
62. Olovnikov I, Chan K, Sachidanandam R, Newman DK, Aravin AA. 2013. Bacterial Argonaute samples the transcriptome to identify foreign DNA. Mol. Cell 51:594-605
63. Richter C, Chang JT, Fineran PC. 2012. Function and regulation of clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR associated (Cas) systems. Viruses 4:2291-311
64. Sorek R, Lawrence CM, Wiedenheft B. 2013. CRISPR-mediated adaptive immune systems in bacteria and archaea. Annu. Rev. Biochem. 82:237-66
65. TernsMP, TernsRM. 2011. CRISPR-based adaptive immune systems. Curr. Opin.Microbiol. 14:321-27
66. Westra ER, Swarts DC, Staals RHJ, Jore MM, Brouns SJJ, van der Oost J. 2012. The CRISPRs, they are a-changin': how prokaryotes generate adaptive immunity. Annu. Rev. Genet. 46:311-39
67. Makarova KS, Haft DH, Barrangou R, Brouns SJJ, Charpentier E, et al. 2011. Evolution and classification of the CRISPR-Cas systems. Nat. Rev. Microbiol. 9:467-77
68. Datsenko KA, Pougach K, Tikhonov A, Wanner BL, Severinov K, Semenova E. 2012. Molecular memory of prior infections activates the CRISPR/Cas adaptive bacterial immunity system. Nat. Commun. 3:945
69. Yosef I,Goren MG,QimronU. 2012. Proteins andDNAelements essential for the CRISPR adaptation process in Escherichia coli. Nucleic Acids Res. 40:5569-76
70. Hale CR, Zhao P, Olson S, Duff MO, Graveley BR, et al. 2009. RNA-guided RNA cleavage by a CRISPR RNA-Cas protein complex. Cell 139:945-56
71. Barrangou R, Fremaux C, Deveau H, Richards M, Boyaval P, et al. 2007. CRISPR provides acquired resistance against viruses in prokaryotes. Science 315:1709-12
72. Fineran PC, Charpentier E. 2012. Memory of viral infections by CRISPR-Cas adaptive immune systems: acquisition of new information. Virology 434:202-9
73. Andersson AF, Banfield JF. 2008. Virus population dynamics and acquired virus resistance in natural microbial communities. Science 320:1047-50
74. Pride DT, Sun CL, Salzman J, Rao N, Loomer P, et al. 2011. Analysis of streptococcal CRISPRs from human saliva reveals substantial sequence diversity within and between subjects over time. Genome Res. 21:126-36
75. Diez-Villasenor C, Guzman NM, Almendros C, Garcia-Martinez J, Mojica FJ. 2013. CRISPR-spacer integration reporter plasmids reveal distinct genuine acquisition specificities among CRISPR-Cas I-E variants of Escherichia coli. RNA Biol. 10:792-802
76. Deveau H, Barrangou R, Garneau JE, Labonte J, Fremaux C, et al. 2008. Phage response to CRISPRencoded resistance in Streptococcus thermophilus. J. Bacteriol. 190:1390-400
77. Mojica FJ,Diez-Villasenor C, Garcia-Martinez J, AlmendrosC. 2009. Short motif sequences determine the targets of the prokaryotic CRISPR defence system. Microbiology 155:733-40
78. Swarts DC,Mosterd C, van PasselMWJ, Brouns SJJ. 2012. CRISPR interference directs strand specific spacer acquisition. PLoS ONE 7:e35888
79. Yosef I, Shitrit D, Goren MG, Burstein D, Pupko T, Qimron U. 2013. DNA motifs determining the efficiency of adaptation into the Escherichia coli CRISPR array. Proc. Natl. Acad. Sci. USA 110:14396-401
80. Vercoe RB, Chang JT, Dy RL, Taylor C, Gristwood T, et al. 2013. Cytotoxic chromosomal targeting by CRISPR/Cas systems can reshape bacterial genomes and expel or remodel pathogenicity islands. PLoS Genet. 9:e1003454
81. Brouns SJJ, Jore MM, Lundgren M, Westra ER, Slijkhuis RJH, et al. 2008. Small CRISPR RNAs guide antiviral defense in prokaryotes. Science 321:960-64
82. Carte J,Wang R, Li H, Terns RM, Terns MP. 2008. Cas6 is an endoribonuclease that generates guide RNAs for invader defense in prokaryotes. Genes Dev. 22:3489-96
83. Haurwitz RE, Jinek M, Wiedenheft B, Zhou K, Doudna JA. 2010. Sequence-and structure-specific RNA processing by a CRISPR endonuclease. Science 329:1355-58
84. Przybilski R, Richter C, Gristwood T, Clulow JS, Vercoe RB, Fineran PC. 2011. Csy4 is responsible for CRISPR RNA processing in Pectobacterium atrosepticum. RNA Biol. 8:517-28
85. Biswas A, Gagnon JN, Brouns SJJ, Fineran PC, Brown CM. 2013. CRISPRTarget: bioinformatic prediction and analysis of crRNA targets. RNA Biol. 10:817-27
86. Marraffini LA, Sontheimer EJ. 2010. Self versus non-self discrimination duringCRISPR RNA-directed immunity. Nature 463:568-71
87. Westra ER, Semenova E,DatsenkoKA, Jackson RN, Wiedenheft B, et al. 2013. Type I-E CRISPR-Cas systems discriminate target from non-targetDNAthrough base pairing-independent PAMrecognition. PLoS Genet. 9:e1003742
88. Wiedenheft B, Lander GC, Zhou K, Jore MM, Brouns SJJ, et al. 2011. Structures of the RNA-guided surveillance complex from a bacterial immune system. Nature 477:486-89
89. Wiedenheft B, van Duijn E, Bultema JB, Waghmare SP, Zhou K, et al. 2011. RNA-guided complex from a bacterial immune system enhances target recognition through seed sequence interactions. Proc. Natl. Acad. Sci. USA 108:10092-97
90. Nam KH, Haitjema C, Liu X, Ding F,Wang H, et al. 2012. Cas5d protein processes pre-crRNA and assembles into a cascade-like interference complex in subtype I-C/DvulgCRISPR-Cas system. Structure 20:1574-84
91. Richter C, Gristwood T, Clulow JS, Fineran PC. 2012. In vivo protein interactions and complex formation in the Pectobacterium atrosepticum subtype I-F CRISPR/Cas system. PLoS ONE 7:e49549
92. Spilman M, Cocozaki A, Hale C, Shao Y, Ramia N, et al. 2013. Structure of an RNA silencing complex of the CRISPR-Cas immune system. Mol. Cell 52:146-52
93. Staals RHJ, Agari Y, Maki-Yonekura S, Zhu Y, Taylor DW, et al. 2013. Structure and activity of the RNA-targeting Type III-B CRISPR-Cas complex of Thermus thermophilus. Mol. Cell 52:135-45
94. Rouillon C, Zhou M, Zhang J, Politis A, Beilsten-Edmands V, et al. 2013. Structure of the CRISPR interference complex CSM reveals key similarities with cascade. Mol. Cell 52:124-34
95. Hatoum-Aslan A, Maniv I, Marraffini LA. 2011. Mature clustered, regularly interspaced, short palindromic repeats RNA (crRNA) length is measured by a ruler mechanism anchored at the precursor processing site. Proc. Natl. Acad. Sci. USA 108:21218-22
96. Deltcheva E, Chylinski K, Sharma CM, Gonzales K, Chao Y, et al. 2011. CRISPR RNA maturation by trans-encoded small RNA and host factor RNase III. Nature 471:602-7
97. Garneau JE, DupuisME, VillionM, Romero DA, Barrangou R, et al. 2010. The CRISPR/Cas bacterial immune system cleaves bacteriophage and plasmid DNA. Nature 468:67-71
98. Jinek M, Chylinski K, Fonfara I, Hauer M, Doudna JA, Charpentier E. 2012. A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science 337:816-21
99. Jore MM, Lundgren M, van Duijn E, Bultema JB, Westra ER, et al. 2011. Structural basis for CRISPR RNA-guided DNA recognition by Cascade. Nat. Struct. Mol. Biol. 18:529-36
100. Reeks J, Naismith JH, White MF. 2013. CRISPR interference: a structural perspective. Biochem. J. 453:155-66
101. Sashital DG, Wiedenheft B, Doudna JA. 2012. Mechanism of foreign DNA selection in a bacterial adaptive immune system. Mol. Cell 46:606-15
102. Semenova E, Jore MM, Datsenko KA, Semenova A,Westra ER, et al. 2011. Interference by clustered regularly interspaced short palindromic repeat (CRISPR) RNA is governed by a seed sequence. Proc. Natl. Acad. Sci. USA 108:10098-103
103. Westra ER, van Erp PBG, Künne T, Wong SP, Staals RHJ, et al. 2012. CRISPR immunity relies on the consecutive binding and degradation of negatively supercoiled invader DNA by Cascade and Cas3. Mol. Cell 46:595-605
104. Li M, Wang R, Zhao D, Xiang H. 2014. Adaptation of the Haloarcula hispanica CRISPR-Cas system to a purified virus strictly requires a priming process. Nucleic Acids Res. 42:2483-92
105. Richter C, Dy RL, McKenzie RE, Watson BNJ, Taylor C, et al. 2014. Priming in the Type I-F CRISPR-Cas system triggers strand-independent spacer acquisition, bi-directionally from the primed protospacer. Nucleic Acids Res. In press. doi: 10.1093/nar/gku527
106. Fineran PC, Gerritzen MJH, Suárez-Diez M, Künne T, Boekhorst J, et al. 2014. Degenerate target sites mediate rapid primed CRISPR adaptation. Proc. Natl. Acad. Sci. USA 111:E1629-38
107. Bondy-Denomy J, Pawluk A, Maxwell KL, Davidson AR. 2013. Bacteriophage genes that inactivate the CRISPR/Cas bacterial immune system. Nature 493:429-32
108. Skennerton CT, Angly FE, Breitbart M, Bragg L, He S, et al. 2011. Phage encoded H-NS: a potential Achilles heel in the bacterial defence system. PLoS ONE 6:e20095
109. PulU,Wurm R, Arslan Z, Geissen R,Hofmann N, Wagner R. 2010. Identification and characterization of E. coli CRISPR-Cas promoters and their silencing by H-NS. Mol. Microbiol. 75:1495-512
110. Westra ER, Pul U, Heidrich N, Jore MM, Lundgren M, et al. 2010. H-NS-mediated repression of CRISPR-based immunity in Escherichia coli K12 can be relieved by the transcription activator LeuO. Mol. Microbiol. 77:1380-93
111. Sebaihia M, Wren BW, Mullany P, Fairweather NF, Minton N, et al. 2006. The multidrug-resistant human pathogen Clostridium difficile has a highly mobile, mosaic genome. Nat. Genet. 38:779-86
112. Seed KD, Lazinski DW, Calderwood SB, Camilli A. 2013. A bacteriophage encodes its own CRISPR/Cas adaptive response to evade host innate immunity. Nature 494:489-91
113. Fukuyo M, Sasaki A, Kobayashi I. 2012. Success of a suicidal defense strategy against infection in a structured habitat. Sci. Rep. 2:238
114. Snyder L, McWilliams K. 1989. The rex genes of bacteriophage λ can inhibit cell function without phage superinfection. Gene 81:17-24
115. Landsmann J, Kroger M, Hobom G. 1982. The rex region of bacteriophage λ: two genes under threeway control. Gene 20:11-24
116. Shinedling S, Parma D, Gold L. 1987. Wild-type bacteriophage T4 is restricted by the λ rex genes. J. Virol. 61:3790-94
117. Parma DH, Snyder M, Sobolevski S, Nawroz M, Brody E, Gold L. 1992. The Rex system of bacteriophage λ: tolerance and altruistic cell death. Genes Dev. 6:497-510
118. Friedman DI, Mozola CC, Beeri K, Ko CC, Reynolds JL. 2011. Activation of a prophage-encoded tyrosine kinase by a heterologous infecting phage results in a self-inflicted abortive infection. Mol. Microbiol. 82:567-77
119. Cheng X,WangW, Molineux IJ. 2004. F exclusion of bacteriophage T7 occurs at the cell membrane. Virology 326:340-52
120. Schmitt CK, Molineux IJ. 1991. Expression of gene 1.2 and gene 10 of bacteriophage T7 is lethal to F plasmid-containing Escherichia coli. J. Bacteriol. 173:1536-43
121. Molineux IJ, Schmitt CK, Condreay JP. 1989. Mutants of bacteriophage T7 that escape F restriction. J. Mol. Biol. 207:563-74
122. Schmitt CK, Kemp P, Molineux IJ. 1991. Genes 1.2 and 10 of bacteriophages T3 and T7 determine the permeability lesions observed in infected cells of Escherichia coli expressing the F plasmid gene pifA. J. Bacteriol. 173:6507-14
123. Kao C, Snyder L. 1988. The lit gene product which blocks bacteriophage T4 late gene expression is a membrane protein encoded by a cryptic DNA element, e14. J. Bacteriol. 170:2056-62
124. Georgiou T, Yu YN, Ekunwe S, Buttner MJ, Zuurmond A, et al. 1998. Specific peptide-activated proteolytic cleavage of Escherichia coli elongation factor Tu. Proc. Natl. Acad. Sci. USA 95:2891-95
125. Yu YT, Snyder L. 1994. Translation elongation factor Tu cleaved by a phage-exclusion system. Proc. Natl. Acad. Sci. USA 91:802-6
126. BinghamR,Ekunwe SI, Falk S, SnyderL,Kleanthous C. 2000. Themajor head protein of bacteriophage T4 binds specifically to elongation factor Tu. J. Biol. Chem. 275:23219-26
127. Depew RE, Cozzarelli NR. 1974. Genetics and physiology of bacteriophage T4 3'-phosphatase: evidence for involvement of the enzyme in T4 DNA metabolism. J. Virol. 13:888-97
128. Kaufmann G, David M, Borasio GD, Teichmann A, Paz A, Amitsur M. 1986. Phage and host genetic determinants of the specific anticodon loop cleavages in bacteriophage T4-infected Escherichia coli CTr5X. J. Mol. Biol. 188:15-22
129. Levitz R, Chapman D, Amitsur M, Green R, Snyder L, Kaufmann G. 1990. The optional E. coli prr locus encodes a latent form of phage T4-induced anticodon nuclease. EMBO J. 9:1383-89
130. Amitsur M, Morad I, Chapman-Shimshoni D, Kaufmann G. 1992. HSD restriction-modification proteins partake in latent anticodon nuclease. EMBO J. 11:3129-34
131. Snyder L. 1995. Phage-exclusion enzymes: a bonanza of biochemical and cell biology reagents? Mol. Microbiol. 15:415-20
132. Chapman D, Morad I, Kaufmann G, Gait MJ, Jorissen L, Snyder L. 1988. Nucleotide and deduced amino acid sequence of stp: the bacteriophage T4 anticodon nuclease gene. J. Mol. Biol. 199:373-77
133. ChopinMC, Chopin A, Bidnenko E. 2005. Phage abortive infection in lactococci: variations on a theme. Curr. Opin. Microbiol. 8:473-79
134. Anba J, Bidnenko E, Hillier A, Ehrlich D, ChopinMC. 1995. Characterization of the lactococcal abiD1 gene coding for phage abortive infection. J. Bacteriol. 177:3818-23
135. Bidnenko E, Chopin A, Ehrlich SD, Chopin MC. 2009. Activation of mRNA translation by phage protein and low temperature: the case of Lactococcus lactis abortive infection system AbiD1. BMC Mol. Biol. 10:4
136. Bidnenko E, ChopinMC, Ehrlich SD, Anba J. 2002. Lactococcus lactis AbiD1 abortive infection efficiency is drastically increased by a phage protein. FEMS Microbiol. Lett. 214:283-87
137. Bidnenko E, Ehrlich SD, ChopinMC. 1998. Lactococcus lactis phage operon coding for an endonuclease homologous to RuvC. Mol. Microbiol. 28:823-34
138. Bidnenko E, Ehrlich D, ChopinMC. 1995. Phage operon involved in sensitivity to the Lactococcus lactis abortive infection mechanism AbiD1. J. Bacteriol. 177:3824-29
139. Emond E,Holler BJ, Boucher I, Vandenbergh PA, Vedamuthu ER, et al. 1997. Phenotypic and genetic characterization of the bacteriophage abortive infection mechanism AbiK from Lactococcus lactis. Appl. Environ. Microbiol. 63:1274-83
140. Fortier LC, Bouchard JD, Moineau S. 2005. Expression and site-directed mutagenesis of the lactococcal abortive phage infection protein AbiK. J. Bacteriol. 187:3721-30
141. Wang C, Villion M, Semper C, Coros C, Moineau S, Zimmerly S. 2011. A reverse transcriptase-related protein mediates phage resistance and polymerizes untemplated DNA in vitro. Nucleic Acids Res. 39:7620-29
142. Bouchard JD, Moineau S. 2004. Lactococcal phage genes involved in sensitivity to AbiK and their relation to single-strand annealing proteins. J. Bacteriol. 186:3649-52
143. Scaltriti E, Launay H, Genois MM, Bron P, Rivetti C, et al. 2011. Lactococcal phage p2 ORF35-Sak3 is an ATPase involved in DNA recombination and AbiK mechanism. Mol. Microbiol. 80:102-16
144. Durmaz E, Klaenhammer TR. 2007. Abortive phage resistance mechanism AbiZ speeds the lysis clock to cause premature lysis of phage-infected Lactococcus lactis. J. Bacteriol. 189:1417-25
145. Prevots F, Tolou S, Delpech B, Kaghad M, DaloyauM. 1998. Nucleotide sequence and analysis of the new chromosomal abortive infection gene abiN of Lactococcus lactis subsp. cremoris S114. FEMS Microbiol. Lett. 159:331-36
146. Prevots F, Ritzenthaler P. 1998. Complete sequence of the new lactococcal abortive phage resistance gene abiO. J. Dairy Sci. 81:1483-85
147. Dai G, Su P, Allison GE, Geller BL, Zhu P, et al. 2001. Molecular characterization of a new abortive infection system (AbiU) from Lactococcus lactis LL51-1. Appl. Environ. Microbiol. 67:5225-32
148. Fineran PC, Blower TR, Foulds IJ, Humphreys DP, Lilley KS, Salmond GP. 2009. The phage abortive infection system, ToxIN, functions as a protein-RNA toxin-antitoxin pair. Proc. Natl. Acad. Sci. USA 106:894-99
149. Gerdes K, Christensen SK, Lobner-Olesen A. 2005. Prokaryotic toxin-antitoxin stress response loci. Nat. Rev. Microbiol. 3:371-82
150. Schuster CF, Bertram R. 2013. Toxin-antitoxin systems are ubiquitous and versatile modulators of prokaryotic cell fate. FEMS Microbiol. Lett. 340:73-85
151. Gerdes K, Larsen JE, Molin S. 1985. Stable inheritance of plasmid R1 requires two different loci. J. Bacteriol. 161:292-98
152. Ogura T, Hiraga S. 1983. Mini-F plasmid genes that couple host cell division to plasmid proliferation. Proc. Natl. Acad. Sci. USA 80:4784-88
153. Kumar P, Issac B, Dodson EJ, Turkenburg JP, Mande SC. 2008. Crystal structure of Mycobacterium tuberculosis YefM antitoxin reveals that it is not an intrinsically unstructured protein. J. Mol. Biol. 383:482-93
154. Christensen SK, Mikkelsen M, Pedersen K, Gerdes K. 2001. RelE, a global inhibitor of translation, is activated during nutritional stress. Proc. Natl. Acad. Sci. USA 98:14328-33
155. Overgaard M, Borch J, Jorgensen MG, Gerdes K. 2008. Messenger RNA interferase RelE controls relBE transcription by conditional cooperativity. Mol. Microbiol. 69:841-57
156. Dy RL, Przybilski R, Semeijn K, Salmond GP, Fineran PC. 2014. A widespread bacteriophage abortive infection system functions through a Type IVtoxin-antitoxin mechanism. Nucleic Acids Res. 42:4590-605
157. Amitai S, Yassin Y, Engelberg-Kulka H. 2004. MazF-mediated cell death in Escherichia coli: a point of no return. J. Bacteriol. 186:8295-300
158. Cook GM, Robson JR, Frampton RA, McKenzie J, Przybilski R, et al. 2013. Ribonucleases in bacterial toxin-antitoxin systems. Biochim. Biophys. Acta 1829:523-31
159. Fozo EM, Hemm MR, Storz G. 2008. Small toxic proteins and the antisense RNAs that repress them. Microbiol. Mol. Biol. Rev. 72:579-89
160. Masuda H, Tan Q, Awano N, Wu KP, Inouye M. 2012. YeeU enhances the bundling of cytoskeletal polymers of MreB and FtsZ, antagonizing the CbtA (YeeV) toxicity in Escherichia coli. Mol. Microbiol. 84:979-89
161. Wang X, Lord DM, Cheng HY, Osbourne DO, Hong SH, et al. 2012. A new Type V toxin-antitoxin system where mRNA for toxin GhoT is cleaved by antitoxin GhoS. Nat. Chem. Biol. 8:855-61
162. Pecota DC, Wood TK. 1996. Exclusion of T4 phage by the hok/sok killer locus from plasmid R1. J. Bacteriol. 178:2044-50
163. Blower TR, Pei XY, Short FL, Fineran PC, Humphreys DP, et al. 2011. A processed noncoding RNA regulates an altruistic bacterial antiviral system. Nat. Struct. Mol. Biol. 18:185-90
164. Blower TR, Fineran PC, Johnson MJ, Toth IK, Humphreys DP, Salmond GP. 2009. Mutagenesis and functional characterization of the RNA and protein components of the toxIN abortive infection and toxin-antitoxin locus of Erwinia. J. Bacteriol. 191:6029-39
165. Blower TR, Short FL, Rao F, Mizuguchi K, Pei XY, et al. 2012. Identification and classification of bacterial Type III toxin-antitoxin systems encoded in chromosomal and plasmid genomes. Nucleic Acids Res. 40:6158-73
166. Short FL, Pei XY, Blower TR, Ong SL, Fineran PC, et al. 2013. Selectivity and self-assembly in the control of a bacterial toxin by an antitoxic noncoding RNA pseudoknot. Proc. Natl. Acad. Sci. USA 110:E241-49
167. Emond E, Dion E, Walker SA, Vedamuthu ER, Kondo JK, Moineau S. 1998. AbiQ, an abortive infection mechanism from Lactococcus lactis. Appl. Environ. Microbiol. 64:4748-56
168. Samson JE, Spinelli S, Cambillau C, Moineau S. 2013. Structure and activity of AbiQ, a lactococcal endoribonuclease belonging to the Type III toxin-antitoxin system. Mol. Microbiol. 87:756-68
169. Blower TR, Evans TJ, Przybilski R, Fineran PC, Salmond GP. 2012. Viral evasion of a bacterial suicide system by RNA-based molecular mimicry enables infectious altruism. PLoS Genet. 8:e1003023
170. Samson JE, Belanger M, Moineau S. 2013. Effect of the abortive infection mechanism and Type III toxin/antitoxin system AbiQ on the lytic cycle of Lactococcus lactis phages. J. Bacteriol. 195:3947-56
171. Otsuka Y, Yonesaki T. 2012. Dmd of bacteriophage T4 functions as an antitoxin against Escherichia coli LsoA and RnlA toxins. Mol. Microbiol. 83:669-81
172. Koga M, Otsuka Y, Lemire S, Yonesaki T. 2011. Escherichia coli rnlA and rnlB compose a novel toxinantitoxin system. Genetics 187:123-30
173. Wei Y, Gao ZQ, Otsuka Y, Naka K, Yonesaki T, et al. 2013. Structure-function studies of Escherichia coli RnlA reveal a novel toxin structure involved in bacteriophage resistance. Mol. Microbiol. 90:956-65
174. Hazan R, Engelberg-KulkaH. 2004. Escherichia coli mazEF-mediated cell death as a defensemechanism that inhibits the spread of phage P1. Mol. Genet. Genomics 272:227-34
175. Guglielmini J, Szpirer C, Milinkovitch MC. 2008. Automated discovery and phylogenetic analysis of new toxin-antitoxin systems. BMC Microbiol. 8:104
176. Sberro H, Leavitt A,Kiro R,Koh E, Peleg Y, et al. 2013. Discovery of functional toxin/antitoxin systems in bacteria by shotgun cloning. Mol. Cell 50:136-48
177. Garvey P, Fitzgerald GF, Hill C. 1995. Cloning and DNA sequence analysis of two abortive infection phage resistance determinants from the lactococcal plasmid pNP40. Appl. Environ. Microbiol. 61:4321-28
178. Erdmann S,LeMoine Bauer S,Garrett RA. 2014. Inter-viral conflicts that exploit host CRISPR immune systems of Sulfolobus. Mol. Microbiol. 91:900-17
179. Dupuis ME, Villion M, Magadan AH, Moineau S. 2013. CRISPR-Cas and restriction-modification systems are compatible and increase phage resistance. Nat. Commun. 4:2087
180. Garvey P, Hill C, Fitzgerald GF. 1996. The lactococcal plasmid pNP40 encodes a third bacteriophage resistance mechanism, one which affects phage DNA penetration. Appl. Environ. Microbiol. 62:676-79